1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Previous Advocacy Updates

Previous Advocacy Updates

  • July 16, 2019

    The CAP opposed the No Surprises Act because it fails to include an independent dispute resolution process that’s successfully proven to keep patients from receiving surprise medical bills.

  • July 2, 2019

    The CAP supports the Protecting People from Surprise Medical Bills Act legislation, which has earned 40 cosponsors in the House.

  • June 25, 2019

    Citing concerns over a payment formula that creates imbalance and threatens patient access to pathology services, the CAP opposed the out-of-network reimbursement provisions included in the latest Surprise Medical Billing legislation.

  • June 18, 2019

    The CAP urged lawmakers to establish a fair arbitration process while holding patients harmless when physicians services are unexpectedly provided out of network. 

  • June 11, 2019

    The CAP led a delegation of pathologists at the 2019 American Medical Association Annual Meeting to set policy affecting the practice of medicine the weekend of June 8.

  • June 4, 2019

    The CAP will lead a delegation of pathologists at the 2019 AMA annual meeting to set policy that affects the practice of medicine.

  • May 21, 2019

    The CAP commended the Washington state law that will protect patients from surprise out-of-network medical bills.

  • May 14, 2019

    The White House hosts event on Surprise Medical Bills and the CAP continues to advocate to protect patients.

  • May 7, 2019

    CAP members made an impact on health policy by meeting with their federal legislators to advocate for patients and the pathology specialty in Washington, DC.

  • April 30, 2019

    CAP members came to Washington, DC, to advocate how Medicare should reimburse clinical laboratory tests and to protect patients from surprise medical bills.

  • April 23, 2019

    At the 2019 Policy Meeting, CAP members will go to Capitol Hill to advocate for policies that protect patients from surprise medical bills and ensure an accurate, market-based payment system for laboratories paid through the Medicare clinical laboratory fee schedule.

  • April 16, 2019

    As part of legislation enacted in 2018 to address the opioid crisis, Congress included the Eliminating Kickbacks in Recovery Act in the final bill. 

  • April 9, 2019

    The CAP is concerned about inconsistent guidance from the National Correct Coding Initiative Policy Manual that affects payment for laboratory tests.

  • April 2, 2019

    The CAP urged the CMS to change its NCD policy implementation on NGS for patients with advanced cancer and continues to engage with the CMS.

  • March 26, 2019

    By using CAP-developed quality measures in 2017, the vast majority of pathologists stopped a 4% Medicare penalty and optimized their Merit-based Incentive Payment System (MIPS) scores to earn positive adjustments to their payments in 2019. 

  • March 19, 2019

    The CAP urged the CMS to include a flexible process that allows for evolving cancer therapy technologies and to ensure recognition of the lifesaving role that pathologists play in the CAR T-cell treatment process. 

  • March 12, 2019

    Still haven’t reported improvement activities for MIPS? The CAP has resources to help members report using the Medicare’s improvement activities attestation portal. And the CAP supports federal agencies for a taskforce to help combat global health outbreaks with critical diagnostic tests.

  • March 5, 2019

    The CAP urges the CMS to reconsider their updated pathology equipment and supplies structure because it does not reflect the proper product, quantity, or unit of measure associated with medical test.

  • February 26, 2019

    The CAP, along with laboratory industry groups, requested a meeting with the Government Accountability Office (GAO) to discuss strong disagreements with a recent GAO report concerning new Medicare payment rates for clinical laboratory services as mandated by PAMA.

  • February 12, 2019

    The CAP advocates with FDA for broader labeling of companion diagnostics to help protect pathologists. Working to ensure patient care is guided by the best test available, the CAP engaged with the FDA in support of broader labeling of companion diagnostics.  

Analysis of Draft 2018 Medicare Rule

Read the special report Right Arrow

Direct questions or comments to:

advocacyupdate@cap.org

202-354-7100

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. Right Arrow
Viewing 1-20 of 218